Abstract
Peptides are short chains of amino acids containing, usually, less than 50–100 residues linked by peptide bonds. A number of peptides have been shown to exist in the cell bodies, as well as in the axons and nerve terminals, of the central nervous system and, by definition, these are called brain peptides or neuropeptides. Neuropeptides have been identified in different brain regions, and neuronal peptidergic pathways have been visualized and characterized in the central nervous system by means of different immunocytochemical, immunofluorescence and radioreceptor assay techniques. For most brain peptides, the localization of their neuronal pathways has been one of the most powerful tools in the understanding of their functions.
This is a preview of subscription content, log in via an institution.
Preview
Unable to display preview. Download preview PDF.
References
Abbott, J., Butt, A.M. and Zloković, B.V. (1988). Techniques for study of blood-brain barrier in non-mammalian species. In Rakić, Lj., Begley, D.J., Davson, H. and Zloković, B.V. (Eds), Peptide and Amino Acid Transport Mechanisms in the Central Nervous System. Macmillan, London, pp. 293–397
Adam, G., Joó, F., Temesvari, P., Dux, E. and Szerdahelyi, P. (1988). Effects of acute hypoxia on the adenylate cyclase activity and albumin transport of brain microvessels. Neurochem. Int. (in press)
Akmal, M.D., Goldstein, A., Multani, S. and Massry, S.G. (1984). Role of uremia, brain calcium and parathyroid hormone on changes in electroencephalogram in chronic renal failure. Am. J. Physiol., 246, F575–F579
Aldred, A.R., Dickson, P.W., Marley, P.D. and Schreiber, G. (1987). Distribution of transferrin synthesis in brain and other tissues in the rat. J. Biol. Chem., 262, 5293–5297
Banks, W.A. and Kastin, A.J. (1983). CSF-plasma relationships for DSIP and some other neuropeptides. Pharmacol. Biochem. Behav., 19, 1037–1040
Banks, W.A. and Kastin, A.J. (1985). Aluminium alters blood-brain barrier permeability to non-peptides. Neuropharmacology, 24, 407–412
Banks, W.A. and Kastin, A.J. (1986a). Aging, peptides and the blood-brain barrier: implications and speculations. In Crook, T., Bartus, R., Ferris, S. and Gerhson, S.M. (Eds), Treatment Development Strategies for Alzheimer’s Disease. Powley Associates, Madison, Conn., pp. 245–265
Banks, W.A. and Kastin, A.J. (1989b). Modulation of the carrier-mediated transport of Tyr-MIF-1 across the blood-brain barrier by essential amino acids. J. Pharmacol., 239, 668–672
Banks, W.A. and Kastin, A.J. (1988a). Peptides and the blood-brain barrier. In Rakić, Lj., Begley, Dj., Davson, H. and Zloković, B.V. (Eds), Peptide and Amino Acid Transport Mechanisms in the Central Nervous System. Macmillan, London, pp. 21–32
Banks, W.A. and Kastin, A.J. (1988b). Twenty-one hormones fail to inhibit the brain to blood transport system for Tyr-MIF-1 and the enkephalins in mice. J. Pharm. Pharmacol., 40, 289–291
Banks, W.A., Kastin, A.J. and Coy, D.H. (1983). Delta sleep-inducing peptide (DSIP)-like materials absorbed by the gastrointestinal tract of the neonatal rat. Life Sci., 33, 1587–1897
Banks, W.A., Kastin, A.J., Fishman, A.J., Coy, D.H. and Strauss, S.L. (1986). Carrier mediated transport of enkephalins and N-Tyr-MIF-1 across the blood-brain barrier. Am. J. Physiol., 251 (Endocrinol. Metab., 14), E477—E482
Banks, W.A., Kastin, A.J., Horvath, A. and Michals, E.A. (1987). Carrier-mediated transport of vasopressin across the blood-brain barrier of the mouse. J. Neurosci. Res., 18, 326–332
Banks, W.A., Kastin, A.J. and Nager, B.J. (1988). Analgesia and the blood-brain barrier transport system for Tyr-MIF-1 enkephalin: evidence for dissociation. Neuropharmaco-logy, 27, 175–179
Banks, W.A., Kastin, A.J. and Siznick, J.K. (1985). Modulation of inununoactive levels of DSIP and blood-brain barrier permeability by lighting and diurnal rhythm. J. Neurosci. Res., 14, 347–355
Bar, R.S., DeRose, A., Sandra, A., Peacock, M.L. and Owen, W.G. (1983). Insulin binding to microvascular endothelium of intact heart: a kinetic and morphometric analysis. Am. J. Physiol., 244, E447–E543
Barrera, C.M., Kastin, A.J. and Banks, W.A. (1987). D-[Ala1]-Peptide T amide is transported from blood to brain by a saturable system. , 19, 629–633
Barry, D.I., Paulson, O.B. and Hertz, M.M. (1980). The blood-brain barrier: an overview with special reference to insulin effect on glucose transport. Acta Neurol. Scand., 778, 147–156
Baskin, D.G., Dorsa, D.M., Figlewicz, D.P., Corp, E.S., Wilcox, B.J., Wallum, B.J. and Woods, S.C. (1988). Insulin as a regulatory peptide in the CNS. In Rakić, Lj., Begley, D.J., Davson, H. and Zloković, B.V. (Eds), Peptide and Amino Acid Transport Mechanisms in the Central Nervous System. Macmillan, London, pp. 79–90
Baskin, D.G., Figlewicz, D.P., Woods, S.C., Porte, D. and Dorsa, D.M. (1987). Insulin in the brain. Ann. Rev. Physiol., 49, 335–347
Baskin, D.G., Woods, S.C., West, D.B., van Houten, M., Posner, B.I., Dorsa, D.M. and Porte, D. Jr. (1983). Immunocytochemical detection of insulin in rat hypothalamus and its possible uptake from cerebrospinal fluid. Endocrinology, 112, 1818–1825
Bayliss, W.M. and Starling, E.H. (1902). The mechanism of pancreatic secretion, J. Physiol, 28, 325–353
Beckwith, B.E., Couk, D.I. and Till, T.S. (1983). Vasopressin analog influences the performance of males on a reaction time task. Peptides, 4, 707–709
Begley, D.J. and Chain, D.G. (1982). Clearance of glutamic acid, glutamine and pyroglutamic acid from the cerebrospinal fluid of the rabbit: a comparison with thyrotropin releasing hormone. J. Physiol., 326, 22–23
Begley, D.J. and Chain, D.G. (1988). Transport of encephalin from cerebrospinal fluid of the rabbit. In Rakić, Lj., Begley, D.G., Davson, H. and Zloković, B.V. (Eds), Peptide and Amino Acid Transport Mechanisms in the Central Nervous System. Macmillan, London, pp. 55–64
Begley, D.J., Michaelson, I.A. and Davson, H. (1980). Clearance of the dipeptide glycyl-L-leucine from rabbit cerebrospinal fluid. J. Physiol., 307, 83P
Begley, D.J., Squires, L.K., Zloković, B.V. and Mitrović, D.M. (1990). Permeability of blood-brain barrier to the immuno-suppressive cyclic peptide cyclosporin A. J. Neurochem., 55, 1222–1230
Begley, J.D. and Zloković, B.V. (1986). Neuropeptides and the blood-brain barrier. In Suckling, A.J., Rumsby, M.G. and Bradbury, M.W. (Eds), Blood-Brain Barrier in Health and Disease. Verlagsgesellschaft, Weinheim, 98–108
Ben-Jonathan, N., Mical, R.S. and Porter, J.C. (1974). Transport of LRF from CSF to hypophysial portal systemic blood and the release of LH. Endocrinology, 95, 18–25
Bloom, F.E. (1987). Molecular diversity and cellular functions of neuropeptides. In de Kloet, E.R., Wiegant, A.M. and de Wied, D. (Eds), Neuropeptides and Brain Function. Progress in Brain Research, Vol. 72, pp. 213–223
Boyles, J.K., Pitas, R.E., Wilson, E., Mahley, R.W. and Taylor, J.M. (1985). Apolipopro-tein, E: associated with astrocytic glia of the central nervous system and with non-myelinating glia of the peripheral nervous system. J. Clin. Invest., 76, 1501
Bradbury, W.B. (1989). Transport across the blood-brain barrier. In Neuwelt, E.A. (Ed.), Implications of the Blood-Brain Barrier and Its Manipulation. Plenum Medical Book Company. New York. pp. 119–137
Brightman, M.W. and Reese, T.S. (1969). Junctions between intimately opposed cell membranes in the vertebrate brain. J. Cell Biol., 40, 648–677
Broadwell, R.D., Balin, B.J. and Salcman, M. (1988). Transcytotic pathway for blood-borne protein through the blood-brain barrier. Proc. Natl Acad. Sci. USA. 85. 632–636
Broadwell, R.D., Balin, B.J., Salcman, M. and Kaplan, R.S. (1983). Brain-blood barrier? Yes and no. Proc. Natl. Acad Sci. USA, 80 7352–7356
Buijs, R.M. and Van Heerikhuize, J.J. (1982). Vasopressin and oxytocin release in the brain-a synaptic event. Brain Res., 252, 71–76
Burbach, J.P., Kovacs, G.L., De Wied, D., van Nispen, J.W. and Greven, H.M. (1983). A major metabolite of arginine vasopressin in the brain is a highly potent neuropeptide. Science, 221, 1310–1312
Cefalu, W.T. and Pardridge, W.M. (1985). Restrictive transport of a lipid-soluble peptide (cyclosporin) through the blood–brain barrier. J. Neurochem., 45, 1954–1956
Coghlan, J.P., Congiu, M., Denton, D.A., Fei, D.T. and Park, R.G. (1986). Augmented plasma renin levels in dehydrated sheep with periventricular lesions. Brain Res., 376, 416–419
Cohen, S.L., Knight, M., Tamminga, C.A. and Chase, T.N. (1983). Tolerance to the antiavoidance properties of cholecystokinin-octapeptide. Peptides, 4, 67–70
Congiu, M., Denton, D.A., Park, R.G., Penschow, J., Simpson, J.B., Tarjan, E., Weisinger, R.S. and Wright, R.D. (1984). The anterior wall of the third cerebral ventricle and homeostatic responses to dehydration. J. Physiol. (Paris), 79, 421–427
Connelly, J.C., Skidgel, R.A., Schulz, W.W., Johnson, A.R. and Erdos E.G. (1985). Neutral endopeptidase 24.11 in human neutrophils: cleavage of chemotactic peptide. Proc. Natl Acad. Sci. USA, 82, 8737–8741
Cornford, E.M., Braun, L.D., Crane, P.D. and Oldendorf, W.H. (1978). Blood-brain barrier restrictions of peptides and the low uptake of enkephalins. Endocrinology, 103, 1297–1303
Corp, E.S., Woods, S.C., Porte, D., Jr., Dorsa, D.M., Figlewicz, D.P. and Baskin, D.G. (1986). Localization of I-insulin binding sites in the rat hypothalamus by quantitative autoradiography. Neurosci. Lett., 70, 17–22
Davis, J.L. and Pico, R.M. (1984). Arginine vasotocin delays extinction of a conditioned avoidance behavior in neonatal chicks. Peptides, 5, 1221–1223
Davson, H. (1955). A comparative study of the aqueous humor and cerebrospinal fluid in the rabbit. J. Physiol., 129, 11–133
Davson, H. and Oldendorf, W.H. (1967). Transport in the central nervous system. Proc. Roy. Soc. Med., 60, 326–328
Davson, H. and Segal, M.B. (1970). The effects of some inhibitors and accelerators of sodium transport on the turnover of 22Na in the cerebrospinal fluid. J. Physiol., 209, 131–153
Davson, H., Welch, K. and Segal, M.B. (1987). Physiology and Pathophysiology of the Cerebrospinal Fluid. Churchill Livingstone, Edinburgh
Denbow, D.M. and Myers, R.D. (1982). Eating, drinking and temperature responses to intracerebroventricular cholecystokinin in the chick. Peptides, 3, 739–743
Derian, C.K. and Moskowitz, M.A. (1986). Polyphosphoinoside hydrolysis in endothelial cells and carotid artery segments. Bradykinin-2 receptor stimulation is calcium-dependent. J. Biol. Chem., 261, 3831–3837
de Sousa, E.B. and Kuhar, H.J. (1986). Corticotrophin-releasing factor receptors: autoradiographic identification. In Martin, J.B. and Barchas, J.D. (Eds), Neuropeptides in Neurologic and Psychiatric Disease. Raven Press, New York, pp. 179–198
de Wied, D. (1987). The neuropeptide concept. In de Kloet, E.R., Wiegant, N.M. and de Wied, D. (Eds), Neuropeptides and Brain Function. Progress in Brain Research, Vol. 72, Elsevier, Amsterdam, pp. 93–108
de Wied, D., Gaffori, O., van Ree, J.M. and de Jong, W. (1984). Central target for the behavioral effects of vasopressin peptides. Nature, 308, 276–278
Dickson, P.W., Aldred, A.P., Marley, P.D., Guo-Fen, T., Howlett, G J. and Schreiber, G. (1985). High prealbumin and transferrin mRNA levels in the choroid plexus of rat brain. Biochem. Biophys. Res. Commun., 127, 890–895
Doczi, T., Joó, F., Szerdahelyi, P. and Bodosi, M. (1988). Regulation of brain water and electrolyte contents: the opposite actions of central vasopressin and atrial natriuretic factor (ANF). Acta Neurochir., 43, (Suppl.), 186–188
Dodd, J. and Kelly, J.S. (1981). The actions of cholecystokinin and related peptides on pyramidal neurones of the mammalian hippocampus. Brain Res., 205, 337–356
Du Vigneaud, V. (1954). Hormones of the posterior pituitary gland: oxytocin and vasopressin. Harvey Lectures, 50, 1–26
Dux, E. and Joó, F. (1982). Effects of histamine on brain capillaries: fine structural and immunohistochemical studies after intracarotid infusion. Exp. Brain Res., 47, 252–258
Dziegielewska, K.M. and Saunders, N.R. (1988a). The development of the blood-brain barrier: proteins in fetal and neonatal CSF, their nature and origins. In Meisami, E. and Timiras, P.J. (Eds), Handbook of Human Growth and Biological Development. CRC Press, Boca Raton, Florida, pp. 103–118
Dziegielewska, K.M. and Saunders, N.R. (1988b). The origins and functions of proteins in CSF in the developing brain. In Rakić, L., Begley, D.J., Davson, H. and Zloković, B.V. (Eds), Peptide and Amino Acid Transport Mechanisms in the Central Nervous System. Macmillan, London, pp. 105–121
Edvinsson, L., Fahrenburg, J., Hanko, J., McCulloch, J., Owman, C. and Uddman, R. (1981). Vasoactive intestinal polypeptide and effects on cerebral blood flow and metabolism. In Cervos-Navarro, J. and Fritschka, E. (Eds),Cerebral Blood Flow and Metabolism. Raven Press, New York, pp. 147–155
Ermisch, A. (1987). Blood-brain barrier and peptides. Wiss. Z. Karl-Marx-Univ. Leipzig, Math.-Naturmiss. R., 36, 72–77
Ermisch, A., Landgraf, R., Brust, P., Kretzschmar, R. and Hess, J. (1988). Peptide receptors of the cerebral capillary endothelium and the transport of amino acids across the blood–brain barrier. In Rakić, Lj., Begley, D.J., Davson, H. and Zloković, B.V. (Eds), Peptide and Amino Acid Transport Mechanisms in the Central Nervous System. Macmillan, London, pp. 43–55
Ermisch, A., Landgraf, R. and Mobius, P. (1986). Vasopressin and oxytocin in brain areas of rats with high or low behavioral performance. Brain Res., 379, 21–29
Fahzenkrug, J. (1979). Vasoactive intestinal polypeptide: measurement distribution and putative neurotransmitter function. Digestion, 19, 149–169
Feldman, S.C. and Kastin, A.J. (1984). Localization of neurones containing immunoreac-tive delta sleep-inducing peptide in the rat brain: an immunocytochemical study. Neuroscience, 11, 303–317
Figlewicz, D.P., Lacour, F., Sipols, A., Porte, Jr., D. and Woods, S.C. (1987). Gastroenter-opancreatic (GEP) peptides in the central nervous system. Ann. Rev. Physiol., 49, 383–395
Frank, H.J.L., Jankovic-Vokis, T., Pardridge, W.M. and Morris, W.L. (1985). Enhanced insulin binding to blood-brain barrier in vivo and to brain microvessels in vitro in newborn rabbits. Diabetes, 34, 728–733
Frank, H.J.L., Pardridge, W.M., Morris, W.L., Rosenfeld, R.G. and Choi, T.B. (1986). Binding and internalization of insulin and insulin-like growth factors by isolated brain microvessels. Diabetes, 35, 654
Freedman, F. and Johnson, J. (1969). Equilibrium and kinetic properties of the Evans blue-albumin system. Am. J. Physiol., 216, 675–681
Gafford, J.T., Skidgel, R.A., Erdos, E.G. and Hersh, L.B. (1983). Human kidney ‘enkephalinase’, a neutral metalloendopeptidase that cleaves active peptides. Biochemistry, 22, 3265–3271
Gaudreau, P., Quirion, R., St. Pierre, S. and Pert, C.B.(1983). Characterization and visualization of cholecystokinin receptors in rat brain using 3H-pentagastrin. Peptides, 4, 755–762
Giles, T.D. and Sander, G.E. (1983). Mechanism of the cardiovascular response to systemic intravenous administration of leucine-enkephalin in the conscious dog. Peptides, 4, 171–175
Gjedde, A. (1988). Exchange diffusion of large neutral amino acids between blood and brain. In Rakić, Lj., Begley, D.J., Davson, H. and Zloković, B.V.(Eds), Peptide and Amino Acid Transport Mechanisms in the Central Nervous System. Macmillan, London, pp. 213–223
Gjedde, A. and Bodsch, W. (1987). Facilitated diffusion across the blood-brain barriers interactions between receptors and transporters. Wiss. Z. Karl-Marx Univ. Leipzig, Math.-Naturmiss. R., 36 (1), 67–71
Gold, P.W. and Chrousos, G.P. (1985). Clinical studies with corticotropin releasing factor: implications for diagnosis and pathophysiology of depression, Cushing’s disease, and adrenal insufficiency. Psychoneuroendocrinology, 10, 401–419
Gold, P.W., Chrousos, G., Kellner, C., Post, R., Roy, A., Augerinos, P., Schulte, H., Oldfield, E. and Loriaux, D.L. (1984). Psychiatric implications of basic and clinical studies with corticotropin-releasing factor. Am. J. Psychiat., J41, 619–623
Goldman, H. and Murphy, S. (1981). An analog of ACTH/MSH ORG-2766, reduces permeability of the blood-brain barrier. Pharmacol. Biochem. Behav., 14, 845–848
Goldmann, E.E. (1909). Die äussere und innere secretetion des gesunden und kranken organismus im lichte der ‘vitalon tarbung’. Beitz. Klin. Chiurg., 64, 192–265
Goldmann, E.E. (1913). Vitalfarbung am Zentral Nervensystem (Abh. Preuss. Akad. Wiss.). Phys Math. Kl., 1, 1–60
Goodman, R.F., Fricker, L.D. and Snyder, S.H. (1983). Enkephalins. In Kreiger, D.T., Browstein, J. and Martin, J.B. (Eds), Brain Peptides. Wiley, New York, pp. 828–849
Greig, N.H. (1989). Drug delivery to the brain by blood-brain barrier circumvention and drug modification. In Neuwelt, E.A. (Ed.), Implications of the Blood-Brain Barrier and Its Manipulation. Plenum Medical Book Company, New York, pp. 311–312
Griffin, D.E. and Giffels, J. (1982). Study of protein characteristics that influence entry into the cerebrospinal fluid of normal mice and mice with encephalitis. J. Clin. Invest., 70, 289–293
Gros, C., Giros, B. and Schwartz, J.C. (1985). Identification of aminopeptidase M as an enkephalin-inactivating enzyme in rat cerebral membranes. Biochemistry, 24, 2179–2185
Gross, P.M., Kadekaro, M., Andrews, D.W., Sokoloff, L. and Saavedra, J.M. (1985). Selective metabolic stimulation of the subfornical organ and pituitary neural lobe by peripheral angiotensin II. Peptides, 6 (Suppl. 1), 145–152
Guglietta, A., Strunk, C.L., Irons, B.J. and Lazarus, L.H. (1985). Central neuromodulation of gastric acid secretion by bombesin-like peptides. Peptides, 6 (Suppl. 3), 75–81
Hanko, J., Hardebo, J.E. and Owman, C. (1981). In Cervos-Navarro, J. and Fritschka, E. (Eds), Cerebral Microcirculation and Metabolism. Raven Press, New York, pp. 157–161
Harbaugh, R.E., Roberts, D.W., Coombs, D.W., Saunders, R.L. and Reeder, T.M. (1984). Preliminary report: intracranial cholinergic drug infusion in patients with Alzheimer’s disease. Neurosurgery, 15, 514–517
Hassen, A.H., Feuerstein, G. and Faden, A.I. (1983). Differential cardiovascular effects mediated by mu and kappa opiate receptors in hindbrain nuclei. Peptides, 4, 621–625
Heidenreich, K.A., Zahniser, N.R., Berhanu, P., Brandenburg, D. and Olefsky, J.M. (1983). Structural differences between insulin receptors in the brain and peripheral target tissues. J. Biol. Chem., 258, 8527–8530
Hersch, L.B. (1982). Degradation of enkephalins: the search for an enkephalinase. Mol. Cell Biochem., 47, 35–43
Hersch, L.B., Aboukhair, N. and Watson, S. (1987). Immunohistochemical localization of aminopeptidase M in rat brain and periphery: relationship of enzyme localization and enkephalin metabolism. Peptides, 8, 523–532
Hess, J., Gjedde, A. and Jessen, H. (1987). Vasopressin receptors at the blood-brain barrier in rats. Wiss. Z. Karl-Marx-Univ. Leipzig, Math.-Naturmiss. R., 36, 81–83
Hoehler, F.K. and Sandman, C.A.(1981). Effects of alpha-MSH and beta-endorphin on startle reflex in rat. Peptides, 2, Suppl. 1, 137–141
Hoffman, P.L., Szabo, G. and Tabakoff, B. (1988). The effects of vasopressin and related peptides on tolerance to ethanol. In Rakić, Lj., Begley, D.J., Davson, H. and Zloković, B.V. (Eds), Peptide and Amino Acid Transport Mechanisms in the Central Nervous System. Macmillan, London, pp. 147–156
Hoffman, P.L., Walter, R. and Bulat, M. (1977). An enzymatically stable peptide with activity in the central nervous system: its penetration through the blood-CSF barrier. Brain Res., 122, 87
Holtman, J.R., Buller, A.L., Hamosh, P. and Gillis, R. (1986). Central respiratory stimulation produced by thyrotropin-releasing hormone in the cat. Peptides, 7, 207–212
Hoosein, N.M. and Gurd, R.S. (1984). Identification of glucagon receptors in rat brain. Proc. Natl Acad. Sci. USA, 84, 4368–4372
Huang, J.T. (1982). Accumulation of peptides by choroid plexus in vitro: Tyr-D-Ala-Gly as a model. Neurochem. Res., 7, 1541–1548
Huang, J.T. and Lajtha, A. (1978). The accumulations of 3H-enkephalinamide (2-D-alanine-5-methioninamide) in rat brain tissues. Neuropharmacology, 17, 1075–1079
Huang, M., Hanley, D.A. and Rorstad, O.P. (1983). Parathyroid hormone stimulates adenylate cyclase in rat cerebral microvessels. Life Sci., 32, 1009–1014
Huang, M. and Rorstad, O.P. (1983). Effects of vasoactive intestinal polypeptide, monoamines, prostaglandins and 2-choloroadenosine on adenylate cyclase in rat cerebral microvessels. J. Neurochem., 40, 719–726
Huffman, L.J., Campbell, G.T. and Gilmore, J.P. (1983). Renal function and pituitary hormone release during cerebral osmostimulation and TRH in dogs. Peptides, 4, 843–847
Hughes, J., Smith, T.W., Kosterlitz, H.W., Fothergill, L.A., Morgan, B.A. and Morris, H.R. (1975). Identification of two related pentapeptides from the brain with potent opiate agonist activity. Nature, 258, 577–579
Hurley, J.V., Anderson, R.McD. and Sexton P.T. (1981). The fate of plasma protein which escapes from blood vessels of the choroid plexus of the rat-An electron microscopic study. J. Pathol., 134, 57–70
Iversen, L.L., Lee, C.M., Gilbert, R.F., Hunt, S. and Emson, P.C. (1980). Regulation of neuropeptide release. Proc. R. Soc., 210, 91–111
Jackson, I.M. and Lechan, R.M. (1983). Thyrotropin releasing hormone. In Kreiger, D.T., Browstein, J. and Martin, J.B. (Eds), Brain Peptides. Wiley, New York
Jeffries, W.A., Brandon, M.R., Hunt, S.V., Williams, A.F., Gatter, K.C. and Mason, D.Y. (1984). Transferrin receptor on endothelium of brain capillaries. Nature, 312, 162
Johanson, C.E. (1989). Potential for pharmacological manipulation of the blood-cerebrospinal fluid barrier. In Neuwelt, E.A. (Ed.), Implications of the Blood-Brain Barrier and Its Manipulation. Plenum Medical Book Company, New York, pp. 223–261
Jones, P.M. and Robinson, I.C.A.F. (1982). Clearance of neurohypophysial peptides from cerebrospinal fluid. J. Physiol., 326, 23P
Joó, F. (1972). Effect of N6, O6-dibutyryl cyclic 3’,5’-adenosine monophosphate on the pinocytosis of brain capillaries in mice. Experientia, 28, 1470–1471
Joó, F. (1986). New aspects to the function of the cerebral endothelium. Nature, 321, 197–198
Joó, F. (1988). Cyclic nucleotide-mediated regulation of albumin transport in brain microvessels. In Rakić, Lj., Begley, DJ., Davson, H. and Zloković, B.V. (Eds), Peptide and Amino Acid Transport Mechanisms in the Central Nervous System. Macmillan, London, pp. 119–128
Joó, F., Temesvari, P. and Dux, E. (1983). Regulation of the macromolecular transport in the brain microvessels: the role of cyclic GMP. Brain Res., 278, 165–174
Kabat, E.A., Moore, D.H. and Landow, H. (1942). An electrophoretic study of the protein components in the cerebrospinal fluid and their relationship to serum protein. J. Clin. Invest., 21, 571–577
Kalin, N.H., Shelton, S.E., Kraemer, G.W. and McKinney, W.T. (1983). Associated endocrine, physiological and behavioral changes in Rhesus monkeys after intravenous corticotropin-releasing factor administration. Peptides, 4, 211–215
Kapadia, S.E. and DeLanerolle, N.C. (1984). Immunohistochemical and electron micro-scopic demonstration of vascular innervation in the mammalian brainstem. Brain Res., 292, 33–39
Karnushina, I., Palacios, J.M., Barbin, G., Dux, E., Joó, F. and Schwartz, J.C. (1980). Studies on a capillary-rich fraction isolated from brain: histaminic components and characterization of the histamine receptors linked to adenylate cyclase. J. Neurochem., 34, 1201–1208
Kastin, A.J. and Dickson, J.C. (1987). Hypophysectomy increases Tyr-MIF-1 like immunoreactivity in rat plasma. Neuroendocrinology, 45, 177–181
Kastin, A.J., Nissan, C. and Coy, D.H. (1981). Permeability of blood-brain barrier to DSIP peptides. Pharmacol. Biochem. Behav., 15, 955–959
Kastin, A.J., Nissan, C., Schally, A.V. and Coy, D.H. (1976). Blood-brain barrier, half time disappearance, and brain distribution for labeled enkephalin and a potent analog. Brain Res. Bull., 1, 583–589
Kastin, A.J., Olson, R.D., Schally, A.V. and Coy, D.H. (1979). CNS effects of peripherally administered peptides. Life Sci., 25, 401–414
Katusic, Z.S., Shepherd, J.T. and Vanhoutte, P.M. (1984). Vasopressin causes endothe-lium-dependent relaxations of the canine basilar artery. Circ. Res., 55 (5), 575–579
Katusic, Z.S., Shepherd, J.T. and Vanhoutte, P.M. (1986). Oxytocin causes endothelium-dependent relaxations of canine basilar arteries by activating Vl-vasopressinergic recep-tors. J. Pharmacol. Exp. Ther., 236, 166–170
Kordon, C., Blauet-Pajot, M.T., Clausen, H., Drouva, S., Enjabert, A. and Epelbaum, Y. (1987). New designs in neuroendocrine systems. In de Kloet, E.R., Wiegant, N.M. and de Wied, D.C. (Eds), Neuropeptides and Brain Function. Progress in Brain Research, Vol. 72, Elsevier, Amsterdam, pp. 27–34
Koslo, R.J., Gmerek, D.E. and Porreca, F. (1986). Intrathecal bombesin-induced inhibition of gastrointestinal transit: requirement for an intact pituitary-adrenal axis. Reg. Peptides, 14, 237–242
Kowarski, D., Shuman, H., Somlyo, A.P. and Somlyo, A.V. (1985). Calcium release by noradrenaline from central sarcoplasmic reticulum in rabbit main pulmonary artery smooth muscle. J. Physiol., 366, 153–175
Kragh-Hansen, U. (1981). Molecular aspects of ligand binding to serum albumin. Pharmacol. Rev., 33, 17–53
Kretzschmar, R., Landgraf, R., Gjedde, A. and Ermisch, A. (1986). Vasopressin binds to microvessels from rat hippocampus. Brain Res., 380, 325–330
Kreiger, D.T. (1986). An overview of neuropeptides. In Martin, J.B. and Barchas, J.D. (Eds), Neuropeptides in Neurologic and Psychiatric Diseases. Raven Press, New York, pp. 1–32
Kumagai, A.K., Eisenberg, J. and Pardridge, W.M. (1986). Rapid binding and internaliza-tion of cationized albumin by isolated brain capillaries. Clin. Res., 34, 69A
Kumagai, A.K., Eisenberg, J. and Pardridge, W.M. (1987). Absorption-mediated endocy-tosis and cationized albumin and a beta-endorphin-cationized albumin chimeric peptide by isolated brain capillaries. Model system of blood-brain barrier transport. J. Biol. Chem.,262,15214–15219
Lackoff, A. and Jackson, I.M.D. (1981). Calcium dependency of potassium-stimulated thyrotropin-releasing hormone secretion from rat neurohypophysis in vitro. Neurosci. Lett., 27, 17
Landgraf, R., Hess, J. and Ermisch, A. (1978). The influence of vasopressin on the regional uptake of [3H]orotic acid by rat brain. Acta Biol. Med. Ger., 37, 655–658
Landgraf, R., Hess, J. and Hartmann, E. (1977). Der Einfluss von Ocytocin auf die regionale 3H Orotsaure-Aufnahme durch das Rattengehirn. Endokrinologie, 70, 45–52
Lee, R.J. and Lomax, P. (1983). Thermoregulatory, behavioral and seizure modulatory effects of AVP in the gerbil. Peptides, 4, 801–805
Lenhard, L. and Deftos, L.J. (1982). Adenohypophysial hormones in the CSF. Neuro-endocrinology, 34, 303–308
Levin, MJ., Tuil, D., Uzan, G., Dreyfus, J.C. and Kahn, A. (1984). Expression of the transferrin gene during development of nonhepatic tissues: high levels of transferrin mRNA in fetal muscle and adult brain. Biochem. Biophys. Res. Commun., 122, 212
Levine, R., Frederics, W. and Rapoport, S. (1982). Entry of bilirubin into the brain due to opening of the blood-brain barrier. Pediatrics, 69, 255–259
Levitan, H., Ziylan, Z., Smith, Q. et al. (1984). Brain uptake of food dye, erythrosin B, prevented by plasma protein binding. Brain Res., 322, 131–134
Lipton, J.M. and Glyn, J.R. (1980). Central administration of peptides alters thermoregula-tion in the rabbit. Peptides, 1, 15–18
McComb, J.G. (1983). Recent research into the nature of cerebrospinal fluid formation and absorption. J. Neurosurg, 59, 369–383
McKinley, M.J., Allen, A., Clevers, T., Dentin, D.A., Mendlesohn, F.A.O., Oldfield, B.J., Tarjan, E. and Weisirger, R.S. (1987). Angiotensin II receptors in the brain of the sheep. Wiss. Z. Karl-Marx-Univ. LeipzigMath.-Naturwiss. R., 36, 189–192
Makara, G.B. (1985). Mechanism by which stressful stimuli activate the pituitary-adrenal system. Fed. Proc., 45, 149–153
Matsas, R., Stephenson, S.L., Hryszko, J., Kenny, A.J., and Turner, A.J. (1985). The metabolism of neuropeptides: phase separation of synaptic membrane preparations with triton X-114 reveals the presence of aminopeptidase N. Biochem. J., 231, 445–449
Matsumoto, T., Kanaide, H., Nishimura, J., Shogakiuchi, Kobayshi, S. and Nakamura, M. (1986). Histamine activates H1-receptors to induce cytosolic free calcium transients in cultured vascular smooth muscle cells from rat aorta. Biochem. Biophys. Res. Commun., 135, 172–177
Meisenberg, G. and Simmons, W.H. (1983). Peptides and the blood-brain barrier. Life Sci., 32, 2611–2633
Mess, B. and Trentini, G.P. (1974). 3H-melatonin level in cerebrospinal fluid and choroid plexus following intravenous administration of the labeled compound. Acta Physiol. Acad. Sci. Hung., 45, 225–231
Milhorat, T.H., Davis, D.A. and Lloyd, B.J. (1973). Two morphologically distinct blood-brain barriers preventing entry of cytochrome c into cerebrospinal fluid. Science, 180, 76–78
Møllgard, K., Balslev, Y. and Saunders, N. (1988). Structural aspects of the blood-brain and blood-CSF barriers with respect to endogenous proteins. In Rakić, Lj., Begley, D.J., Davson, H. and Zloković, B.V. (Eds). Peptide and Amino Acid Transport Mechanisms in the Central Nervous System. Macmillan, London, pp. 93–101
Møllgard, K. and Saunders, N.R. (1977). A possible transepithelial pathway via endoplas-mic reticulum in foetal sheep choroid plexus. Proc. Roy. Soc. B, 199, 321–326
Møllgard, K. and Saunders, N.R. (1986). The development of the human blood-brain and blood-CSF barriers. Neuropath. Appl. Neurobiol., 12, 337–358
Moody, T.W., O’Donohue, T.L. and Jacobowitz, D.M. (1981). Biochemical localization and characterization of bombesin-like peptides in discrete regions of rat brain. Peptides, 2, 75–79
Morimoto, S., Nishimura, J., Miyauchi, A., Takai, S.I., Okada, Y., Onishi, T., Fukuo, K., Lee, S. and Kumahara, Y. (1982). Calcitonin in plasma and cerebrospinal fluid from normal subjects and patients with medullary thyroid carinoma: possible restriction of calcitonin by blood-brain barrier. J. Clin. Endocrinol. Metab., 55, 597–596
Morley, J.E., Levine, A., Oken, M.M., Grace, M. and Kneip, J. (1982). Neuropeptides and thermoregulation: the interactions of bombesin, neurotensin, TRH, somatostatin, nalox-one and prostaglandins. Peptides, 3, 1–6
Neuwelt, E.A. and Rapoport, S.I. (1984). Modification of the blood-brain barrier in the chemotherapy of malignant brain tumors. Fed. Proc., 43, 214–221
Niewoehner, D.E., Levine, A.S. and Morley, J.E. (1983). Central effects of neuropeptides on ventilation in the rat. Peptides, 4, 277–281
North, A.R. (1986). Electrophysiological effects of neuropeptides. In Martin, J.B. and Broebes, J.D. (Eds), Neuropeptides in Neurologic and Psychiatric Disease. Raven Press, New York, pp. 71–77
Ohno, K., Pettigrew, K.D. and Rapoport, S.I. (1978). Lower limits of cerebrovascular permeability to non-electrolytes in conscious rat. Am. J. Physiol., 235, H299–H307
Oldendorf, W.M. (1981). Blood-brain barrier permeability to peptides, pitfalls in measure-ment. Peptides, 2 (Suppl. 2), 109–111
Ommaya, A. (1963). A subcutaneous reservoir and pump for sterile access to ventricular cerebrospinal fluid. Lancet ii, 983–984
Pardridge, W.M. (1979). Carrier-mediated transport of thyroid hormones through the rat blood-brain barrier: Primary role of albumin-bound hormone. Endocrinol., 105, 605–612
Pardridge, W.M. (1981). Transport of protein-bound hormones into tissues in vivo. Endocrin. Rev., 2, 103–123
Pardridge, W.M. (1985). Strategies for drug delivery through the blood-brain barrier. In Borchardt, R.T., Repta, A.J. and Stella, V.J. (Eds), Directed Drug Delivery: A Multidisci-plinary Problem. Humana Press Inc., Clifton, N.J. p. 83
Pardridge, W.M. (1986a). Receptor-mediated peptide transport through the blood-brain barrier. Endocr. Rev., 7 (3), 31–33
Pardridge, W.M. (1986b). Blood-brain barrier: interface between internal medicine and the brain. Ann. Intern. Med., 105, 82–95
Pardridge, W.M. (1987). Plasma protein mediated transport of steroid and thyroid hormones. Am. J. Physiol., 252, E157–E164
Pardridge, W.M. (1988). Recent advances in blood-brain barrier transport. Ann. Rev. Pharmacol. Toxicol., 28, 25–39
Pardridge, W.M., Eisenberg, J. and Cefalu, W.T. (1985a). Absence of albumin receptor on brain capillaries in vivo or in vitro. Am. J. Physiol., 249, E264
Pardridge, W.M., Eisenberg, J. and Yang, J. (1985b). Human blood-brain barrier insulin receptor. J. Neurochem., 44, 1771
Pardridge, W.M., Eisenberg, J. and Yang, J. (1987). Human blood-brain barrier transferrin receptor. J. Neurochem., 49, 1394–1401
Pardridge, W.M. and Oldendorf, W.H. (1975). Kinetic analysis of blood-brain barrier transport of amino acids. Biochim. Biophys. Acta, 401, 128–136
Pardridge, W.M., Triguero, D. and Buciak, J.L. (1990). β-Endorphin chimeric peptides: transport through the blood-brain barrier in vivo and cleavage of disulfide linkage by brain. Endocrinology, 126 (2), 977–984
Patel, H.M. (1984). Liposomes: bags of challenge. Biochem. Soc. Trans., 12, 333
Peterson, J.S., Kalivas, P.W. and Prasad, C. (1984). Cyclo (His-Pro) (cHP) regulates striatal dopaminergic function. Soc. Neurosci. Abstr., 10, 1123
Posner, B.I., van Houten, M., Patel, B. and Walsh, R.J. (1983). Characterization of lactogen binding sites in choroid plexus. Exp. Brain, 49, 300–306
Prange, A.J., Gazzbutt, J., Loosen, P.T., Bissette, G. and Nemeroff, C.B. (1987). The role of peptides in affective disorders: a review. Prog. Brain Res., 72, 235–279
Prange Jr, AJ., Wilson, I.C., Lara, P.P., Alltop, L.B. and Breese, G.R. (1972). Effects of thyroptropin releasing hormone in depression. Lancet, ii, 999–1002
Rap, Z.M. (1981). Inhibitory effect of antidiuretic hormone on outflow of the cerebrospinal fluid in vasogenic brain edema induced by cold lesion. In Cervos-Navarro, J. and Fritschke, E. (Eds), Cerebral Microcirculation and Metabolism. Raven Press, New York, pp. 171–175
Rap, Z.M., Kozniewska, E. and Skolasinska, K. (1980). Effect of vasopressin on cerebral blood flow and cerebrospinal fluid outflow. In Betz, E., Grobe, J. and Hauser, D. (Eds), Pathophysiology and Pharmacotherapy of Cerebrovascular Disorders. Verlag G. Witzstrock, Köln, pp. 12–14
Rapoport, S.I., Klee, W.A., Pettigrew, K.D. and Olmo, K. (1980). Entry of opioid peptides into the central nervous system. Science, 207, 84–86
Reese, T.S., Feder, N. and Brightman, M.W. (1971). Electron microscopic study of the blood-brain and blood-cerebrospinal fluid barriers with microperoxidase. J. Cell. Biol, 34, 207–217
Reese, T.S. and Karnovsky, M.J. (1967). Fine structural localization of a blood-brain barrier to exogenous peroxidase. J. Cell Biol., 34, 207–217
Reichlin, S. (1983a). Somatostatin. New Engl. J. Med., 309, 1495–1501
Reichlin, S. (1983b). Somatostatin. New Engl. J. Med., 309, 1556–1562
Reith, J., Ermisch, A., Diemer, N.H. and Gjedde, A. (1987). Saturable retention of vasopressin by hippocampus vessels in vivo, associated with inhibition of blood-brain transfer of large neutral amino acids. J. Neurochem., 49, 1471–1479
Rivier, C. and Vale, W. (1985). Effects of corticotropin-releasing factor, neurohypophyseal peptides and catecholamines on pituitary function. Fed. Proc., 44, 189–195
Rogers, R.C. and Hermann, G.E. (1985). Dorsal medullary oxytocin, vasopressin, oxytocin antagonist, and TRH effects on gastric acid secretion and heart rate. Peptides, 6, 1143–1148
Sandman, C.A., Beckwith, B.E. and Kastin, A.J. (1980). Are learning and attention related to the sequence of amino acids in ACTH/MSH peptides? Peptides, 1, 277–280
Sarna, G.S., Bradbury, M.W.B. and Cavanagh, J. (1978). Permeability of the blood-brain barrier after porto-caval anastomosis in the rat. Brain Res., 138, 550–554
Schaffer, M.M. and Moody, T.W. (1986). Autoradiographic visualization of CNS receptors for vasoactive intestinal peptide. Peptides, 7, 283–286
Schivers, B.D., Harlan, R.E., Romano, J.G., Howills, R.D. and Phaff, G.W. (1986). Cellular localization of pre-enkephalin in RNA in rat brain: gene expression in the caudate putamen and cerebral cortex. Proc. Natl Acad. Sci. USA, 83, 6221–6225
Schutz, W., Steuer, G. and Tuisl, E. (1982). Functional identification of adenylate cyclase-coupled adenosine receptors in rat brain microvessels. Eur. PharmacoL, 85, 177–184
Schwartz, J.C. (1983). Metabolism of enkephalins and the inactivating peptide concept. Trends Neursci., 6, 5–8
Schwartz, J.C., Malfroy, B. and De La Baume, S. (1981). Biological inactivation of enkephalins and the role of enkephalin dipeptidyl-carboxypeptidase (‘Enkephalinase’) as neuropeptidase. Life Sci., 29, 1715–1740
Segal, M.B. and Pollay, M. (1977). The secretion of cerebrospinal fluid. Exp. Eye Res., 25 (Suppl.), 205–228
Segal, M.B. and Zloković, B.V. (1990). The Blood-Brain Barrier, Amino Acids and Peptides, Kluwer, Dordrecht, Boston, London
Siggins, G.R. and Groul, D.L. (1986). Synaptic mechanisms in the vertebrate central nervous system. In Bloom, F.E. (Ed.), Handbook of Physiology. Volume on Intrinsic Regulatory Systems of the Brain. American Physiological Society, Bethesda, Maryland, pp. 1–114
Simantov, R. and Snyder, S.H. (1976). Morphine-like peptides in mammalian brain: isolation, structure, elucidation, and interactions with opiate receptors. Proc. Natl Acad. Sci. USA, 73 (7), 2515–2519
Smith, Q.R., Momma, S., Aoyagi, M. and Rapoport, S.I. (1987). Kinetics of neutral amino acid transport across the blood-brain barrier. J. Neurochem., 49, 1651–1658
Smith, Q.R., Takasato, Y. and Rapoport, S. (1984). Kinetic analysis of L-leucine transport across the blood-brain barrier. Brain Res., 311, 167–170
Spector, R. (1977). Vitamin homeostasis in the central nervous system. New Engl. J. Med., 296, 1393–1398
Spector, R. (1982). Nucleoside transport in choroid plexus: Mechanism and specificity. Arch. Biochem. Biophys., 216, 693–703
Speth, R.C. and Harik, S.I. (1985). Angiotensin II receptor binding sites in brain microvessels. Proc. Natl Acad. Sci USA, 82, 6340–6343
Strikant, C.B. and Patel, Y.C. (1981). Somatostatin receptors: identification and character-ization in rat brain membranes. Proc. Natl Acad. Sci. USA, 78, 3930–3934
Stephenson, S.L. and Kenny, A.J. (1987). The hydrolysis of alpha-human atrial natriuretic peptide by pig kidney microvillar membranes is initiated by endopeptidase 24.11. Biochem. J., 243, 183–187
Stewart, P.A. and Wiley, M.J. (1981). Developing nervous tissue induces formation of blood-brain barrier characteristics in invading endothelial cells: a study using quail-chick transplantation chimeras. Dev. Biol, 84, 183–192
Stickrod, G., Kimble, D.P. and Smotherman, W.P. (1982). Met-enkephalin effects on associations formed in utero.Peptides, 3, 881–883
Susic, V. and Masirevic, G. (1988). In Rakić, Lj., Begley, D.J., Davson, H. and Zloković, B.V. (Eds), Peptide and Amino Acid Transport Mechanisms in the Central Nervous System. Macmillan, London, pp. 141–147
Susic, V., Masirevic, G. and Totic, S. (1987). The effects of delta sleep inducing peptides (DSIP) on wakefulness and sleep patterns in the cat. Brain Res., 414, 262–270
Tache, Y., Vale, W., Rivier, J. and Brown, M. (1981). Brain regulation of gastric acid secretion in rats by neurogastrointestinal peptides. Peptides, 2 (Suppl. 2), 51–55
Takasato, J., Momma, S. and Smith, QR. (1985). Kinetic analysis of cerebrovascular isoleucine transport from saline and plasma. J. Neurochem., 45, 1013–1020
Takasato, Y., Rapoport, S.I. and Smith, QR. (1984). An in situ brain perfusion technique to study cerebrovascular transport in the rat. Am. J. Physiol., 247, H484–H493
Tenner, T.E.J., Yang, C.M., Chang, J.K., Schimizu, M. and Pang, P.K.T. (1980). Pharmacological comparison of bPTH-(1–34) and other hypotensive peptides in the dog. Peptides, 1, 285–288
Triguero, D.J., Buciak, J.B., Yang, J. and Pardridge, W.M. (1989). Blood-brain barrier transport of cationized inununoglobulin G: enhanced delivery compared to native protein. Proc. Natl Acad. Sci. USA, 86, 4761–4765
Uddman, R., Edvinsson, L., Owman, C. and Sundler, F. (1981). Perivascular substance P: occurrence and distribution in mammalian pial vessels. J. Cereb. Blood Flow Metab., 1, 227–232
Uddman, R., Edvinsson, L., Owman, C. and Sundler, F. (1983). Nerve fibres containing gastrin-releasing peptide around pial vessels. J. Cereb. Blood Flow Metab., 3, 386–390
Urban, I.J.A. (1981). Brain vasopressin: from electrophysiological effects to neurophysio-logical function. In de Kloet, E.R., Wiegant, V.M. and de Wied, D. (Eds), Neuropeptides and Brain Function. Progress in Brain Research, Vol. 72, pp. 163–172
Van der Velde, C.D. (1983). Rapid clinical effectiveness of MIF-1 in the treatment of major depressive illness. Peptides, 4, 297–300
van Deurs, B. (1977). Vesicular transport of horseradish peroxidase from brain to blood in segments of the cerebral microvasculature in adult mice. Brain Res., 124, 1–8
van Deurs, B. (1980). Structural aspects of brain barriers, with special reference to the permeability of the cerebral endothelium and choroidal epithelium. Intern. Rev. Cytol., 63, 117–191
van Deurs, B., von Bülow, F. and Meller, M. (1981). Vesicular transport of cationized ferritin by the epithelium of the rat choroid plexus. J. Cell Biol., 89, 131–139
Van Dijk, A., Richards, J.G., Trzeeiak, A., Gillessen, D. and Mohler, H. (1984). Cholecystokinin receptors: biochemical demonstration and autoradiographical localiza-tion in rat brain and pancreas using 3H-cholecystokinin as radioligand. J. Neurosci., 4, 1021–1033
van Houten, M. and Posner, B.I. (1983). Circumventricular organs: receptors and mediators of direct peptide hormone action on brain. In Szabo, A. (Ed.), Advances in Metabolic Disorders, Vol. 10. Academic Press, New York, pp. 269–289
Van Ree, J.M., Caffe, A.M. and Wolterink, G. (1982). Non-opiate beta-endorphin fragments and dopamine. III. γ-Type endorphins and various neuroleptics counteract the hypoactivity elicited by injection of apomorphine into the nucleus accumbens. Neuropharmacology, 21, 1111–1117
Van Ree, J.M., Verhoven, Z.K. and de Wied, D. (1987). Animal and clinical research on neuropeptides and schizophrenia. Prog. Brain Res., 72, 249–267
Varagic, V.M., Stojanovic, V. and Dzoljic, E. (1988). The effect of enkephalins and enkephalinase inhibitors on the central cholinergic mechanisms participating in the peripheral adrenergic activation. In Rakić, Lj., Begley, D.j., Davson, H. and Zloković, B.V. (Eds),Peptide and Amino Acid Transport Mechanisms in the Central Nervous System.Macmillan, London, pp. 157–166
Vistica, D.T. (1983). Cellular pharmacokinetics of the phenylalanine mustards. Pharmac. Ther., 22, 379–406
Walsh, R.J., Slaby, F. and Posner, B.I. (1987). Prolactin transport from blood to cerebrospinal fluid: a receptor mediated process. Wiss. Z. Karl-Marx-Univ. Leipzig Math.-Naturmiss. R., 36 (1), 119–120
Wenger, T. (1987). The role of organum vasculosum of the lamina terminals in the regulation of pituitary gonadotrophic hormone secretion. Wiss. Z. Karl-Marx-Univ. Leipzig Math.-Naturroiss. R., 36 (1), 52–55
Westergaard, E. and Brightman, M.W. (1973). Transport of proteins across normal cerebral arterioles. J. Comp. Neurol., 152, 17–44
Wilson, K.M. and Fregley, M.J. (1985). Factors affecting angiotensin II-induced hypother-mia in rats. Peptides, 6, 695–701
Winokur, A., Amsterdam, J., Caroff, S., Snyder, P.J. and Brunswich, D. (1982). Variability of hormonal responses to a series of neuroendocrine challenges in depressed patientsAm. J Psychiatr., 139, 39–44
Wolf, B.A., Turk, J., Sherman, W.R. and McDaniel, M.L. (1986). Intracellular Ca2+ mobilization by arachidonic acid. J. Biol. Chem., 261, 3501–3511
Woods, S.C. and Porte, D. Jr. (1977). Relationship between plasma and cerebrospinal fluid insulin levels of dogs. Am. J. Physiol., 233, E331–E334
Yarbrough, G.G. (1976). TRH potentiates excitatory actions of acetylcholine in cerebral cortical neurons. Nature, 263, 523–524
Zadina, J.E., Banks, W.A. and Kastin, J.E. (1986). Central nervous system effects of peptides 1980–1985. Peptides, 7, 497–537
Zerbe, R.L., Kirtland, S., Faden, A.I. and Feuerstein, G. (1983). Central cardiovascular effects of mammalian neurohypophysical peptides in conscious rats. Peptides, 4, 627–630
Zloković, B.V. (1990). In vivo approaches for studying peptide interactions at the blood-brain barrierJ.Control. Rel., 13, 185–202
Zloković, B.V., Begley, D.J. and Chain, D.G. (1983). Blood-brain barrier permeability to di-peptides and their constituent amino acids. Brain Res., 271, 66–71
Zloković, B.V., Begley, D.J. and Chain-Eliash, D.G. (1985a). Blood-brain barrier per-meability to leucine-enkephalin, D-alanine2 D-leucine5 -enkephalin and their N-terminal amino acid (tyrosine). Brain Res., 336 125–132
Zloković, B.V., Hyman, S., McComb, J.G., Tang, G., Davson, H. and Lipovać, M.N. (1990a). Kinetics of arginine-vasopressin uptake at the blood-brain barrier. Biochim. Biophys. Acta, 1025, 191–198
Zloković, B.V., Lipovac, N.M., Begley, D.J., Davson, H. and Rakić, Lj. (1987). Transport of leucine-enkephalin across the blood-brain barrier in the perfused guinea pig brain. J. Neurochem., 49, 310–315
Zloković, B.V., Lipovac, M.N., Begley, D.J., Davson, H. and Rakić, Lj. (1988a). Slow penetration of thyrotropin releasing hormone across the blood-brain barrier of in situ perfused guinea-pig brain. J. Neurochem., 51, 252–257
Zloković, B.V., McComb, J.G., Perlmutter, L. and Davson, H. (1991). Neuroactive Peptides and Amino Acids at the Blood-Brain Barrier: Possible Implications to Drug Abuse. NIDA Research Monographs, Washington, D.C. (in press)
Zloković, B.V., Mackić, J.B., Duricić, B. and Davson, H. (1989a). Kinetic analysis of leucine-enkephalin cellular uptake by the blood-brain barrier of an in situ perfused guinea-pig brain. J. Neurochem., 53, 1333–1340
Zloković, B.V., Segal, M.B., Begley, D.J., Davson, D.J. and Rakić, Lj. (1985b). Permeabil-ity of the blood-cerebrospinal fluid and blood-brain barriers to thyrotropin releasing hormone. Brain Res., 358, 191–199
Zloković, B.V., Segal, M.B., Davson, H. and Jankov, R.M. (1988b). Passage of delta sleep-inducing peptide (DSIP) across the blood-cerebrospinal fluid barrier. Peptides, 9, 533–538
Zloković, B.V., Skundrić, D., Segal, M.B., Lipovac, M.N., Mackić, J.B. and Davson, H. (1990b). A saturable mechanism for transport of immunoglobulin G across the blood-brain barrier of the guinea-pig. Exp. Neural., 107, 263–270
Zloković, B.V., Susić, V.T., Davson, H., Begley, D.J., Jankov, R.M., Mitrović, D.M. and Lipovac, M.N. (1989b). Saturable mechanisms for delta-sleep inducing peptide (DSIP) at the blood-brain barrier of the vascularly perfused guinea-pig brain. Peptides, 10, 249–254
Author information
Authors and Affiliations
Copyright information
© 1993 The authors
About this chapter
Cite this chapter
Davson, H., Zloković, B., Rakić, L., Segal, M.B. (1993). Peptides and Proteins. In: An Introduction to the Blood-Brain Barrier. Palgrave, London. https://doi.org/10.1007/978-1-349-11882-3_3
Download citation
DOI: https://doi.org/10.1007/978-1-349-11882-3_3
Publisher Name: Palgrave, London
Print ISBN: 978-1-349-11884-7
Online ISBN: 978-1-349-11882-3
eBook Packages: EngineeringEngineering (R0)